(55), 5-methoxypsoralen was found to inhibit PI3K, mTOR, and Akt phosphorylation and expression in human glioma cells, resulting in the inhibition of the PI3K/Akt/mTOR signaling axis. The gene discussed is MTOR; the disease is central nervous system cancer.